Cigna Capital Surpluse from 2010 to 2024

CI Stock  USD 337.80  1.30  0.39%   
Cigna Corp's Capital Surpluse is increasing with slightly volatile movements from year to year. Capital Surpluse is predicted to flatten to about 21.1 B. For the period between 2010 and 2024, Cigna Corp, Capital Surpluse quarterly trend regression had mean deviation of  12,842,992,000 and range of 31.9 B. View All Fundamentals
 
Capital Surpluse  
First Reported
2018-12-31
Previous Quarter
30.4 B
Current Value
30.6 B
Quarterly Volatility
895.1 M
 
Covid
Check Cigna Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cigna Corp's main balance sheet or income statement drivers, such as Interest Expense of 1.5 B, Other Operating Expenses of 196 B or Operating Income of 9 B, as well as many indicators such as Price To Sales Ratio of 0.48, Dividend Yield of 0.0202 or PTB Ratio of 1.42. Cigna financial statements analysis is a perfect complement when working with Cigna Corp Valuation or Volatility modules.
  
Check out the analysis of Cigna Corp Correlation against competitors.
For more detail on how to invest in Cigna Stock please use our How to Invest in Cigna Corp guide.

Latest Cigna Corp's Capital Surpluse Growth Pattern

Below is the plot of the Capital Surpluse of Cigna Corp over the last few years. It is Cigna Corp's Capital Surpluse historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Cigna Corp's overall financial position and show how it may be relating to other accounts over time.
Capital Surpluse10 Years Trend
Slightly volatile
   Capital Surpluse   
       Timeline  

Cigna Capital Surpluse Regression Statistics

Arithmetic Mean14,913,555,000
Geometric Mean8,370,251,333
Coefficient Of Variation91.09
Mean Deviation12,842,992,000
Median2,940,000,000
Standard Deviation13,585,315,117
Sample Variance184560786.8T
Range31.9B
R-Value0.84
Mean Square Error57507066T
R-Squared0.71
Significance0.000079
Slope2,560,872,589
Total Sum of Squares2583851015.8T

Cigna Capital Surpluse History

202421.1 B
202334.8 B
202230.2 B
202129.6 B
202029 B
201928.3 B
201827.8 B

About Cigna Corp Financial Statements

Investors use fundamental indicators, such as Cigna Corp's Capital Surpluse, to determine how well the company is positioned to perform in the future. Although Cigna Corp's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Capital Surpluse34.8 B21.1 B

Currently Active Assets on Macroaxis

Check out the analysis of Cigna Corp Correlation against competitors.
For more detail on how to invest in Cigna Stock please use our How to Invest in Cigna Corp guide.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cigna Corp. If investors know Cigna will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cigna Corp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.45)
Dividend Share
5.43
Earnings Share
10.54
Revenue Per Share
808.024
Quarterly Revenue Growth
0.28
The market value of Cigna Corp is measured differently than its book value, which is the value of Cigna that is recorded on the company's balance sheet. Investors also form their own opinion of Cigna Corp's value that differs from its market value or its book value, called intrinsic value, which is Cigna Corp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cigna Corp's market value can be influenced by many factors that don't directly affect Cigna Corp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cigna Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cigna Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cigna Corp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.